{"version":"1.0","type":"link","title":"Budget Impact of Venetoclax for Newly Diagnosed Patients with Acute Myeloid Leukemia Aged ≥ 75 Years or with Comorbidities Precluding Intensive Chemotherapy in the United States.","author_name":"Xu Y 외","author_url":"https://prs-insight.online/author/Xu%20Y","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/160272","thumbnail_width":1200,"thumbnail_height":630}